Lly Weight Loss Drug - Search News

Weight Loss Drug Demand Drives Eli Lilly Sales

Business Insider · 11h

Eli Lilly (NYSE:LLY) Speeds Up Weight Loss Drug Data Release

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s leader can become

YAHOO!Finance · 12h

Zepbound sales keep soaring, even as weight loss drug growth slows

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations.

Hosted on MSN · 13h

Eli Lilly Adjusted Profit Tops Estimates as Weight-Loss Drug Sales Fall Short

Eli Lilly (LLY) shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue. Eli Lilly reported net income of $4.41 billion, or $4.88 per share,

2d

Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

7don MSN

Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio

Weight-loss drugs are transforming both health care and Wall Street, with leading manufacturers like Eli Lilly & Co. (LLY) ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results